Open Sinus Lift Technique With Simultaneous Implantation Using Platelet Rich Fibrin (PRF) Versus Nano-crystalline Hydroxyapatite

NCT ID: NCT02577289

Last Updated: 2015-10-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

18 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-07-31

Study Completion Date

2017-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluation of bone quantity in open sinus lift technique with space maintaining using platelet rich fibrin (PRF) as sole augmentation material versus nano crystalline hydroxyapatite with simultaneous placing of implants.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Evaluation of bone quantity in open sinus lift technique with simultaneous implantation using platelet rich fibrin (PRF) versus Nano-crystalline Hydroxyapatite as sole grafting material in patients with atrophied posterior maxillary ridge which provides a new modality for treatment of patients with atrophied posterior maxillary ridge with least cost and a much easier way using platelet rich fibrin (PRF) as substitution to bone graft

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrophied Posterior Maxillary Ridge

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control group ( Hydroxyappetite)

Patients will undergo open sinus lift using nano crystalline hydroxyapatite as augmentation material and placing implants simultaneously then evaluation of bone quantity in open sinus lift technique with simultaneous implantation ( Nano crystalline hydroxyapatite)

Group Type ACTIVE_COMPARATOR

Evaluation of bone quantity in open sinus lift technique with simultaneous implantation ( Nano crystalline hydroxyapatite)

Intervention Type PROCEDURE

• The sinus cavity will be augmented with bone graft ( Nano crystalline hydroxyapatite)

Test group (PRF)

Patients will undergo open sinus lift using PRF as sole augmentation material and placing implants simultaneously then Evaluation of bone quantity in open sinus lift technique with simultaneous implantation (PRF)

Group Type EXPERIMENTAL

Evaluation of bone quantity in open sinus lift technique with simultaneous implantation (PRF)

Intervention Type PROCEDURE

platelet rich fibrin (PRF) as sole grafting material in created space (PRF)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Evaluation of bone quantity in open sinus lift technique with simultaneous implantation ( Nano crystalline hydroxyapatite)

• The sinus cavity will be augmented with bone graft ( Nano crystalline hydroxyapatite)

Intervention Type PROCEDURE

Evaluation of bone quantity in open sinus lift technique with simultaneous implantation (PRF)

platelet rich fibrin (PRF) as sole grafting material in created space (PRF)

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients should be seeking for implant supported prosthesis in posterior maxilla bilaterally
* All patients should have atrophied posterior maxillary ridge with the maximum height of the alveolar bone is from 3 mm to 5 mm

Exclusion Criteria

* Ongoing steroid therapy;
* Uncontrolled diabetes;
* Recent cardiovascular diseases;
* Inflammation of the maxillary sinus;
* Previous radiant therapy for neoplastic pathologies
* Patient who have had previous failed sinus augmentation, or exhibited pathological finding or had a history of maxillary sinus disease or operations or whose medical condition might increase surgical risk of the research protocol were excluded.
Minimum Eligible Age

30 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

waleed Mohamed Mohamed Mahmoud nour el din

Master student

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of oral and dental medicine

Cairo, Cairo Governorate, Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Waleed M. Nour El Din, BDS

Role: CONTACT

+2-01001448723

Hesham Abdel Hakm, Professor

Role: CONTACT

+2-01156096060

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

waleed M. Nour El din, BDS

Role: primary

+2-01001448723

Hesham Abdel Hakm, Profeesor

Role: backup

+2-01156096060

References

Explore related publications, articles, or registry entries linked to this study.

Jemt T, Lekholm U. Implant treatment in edentulous maxillae: a 5-year follow-up report on patients with different degrees of jaw resorption. Int J Oral Maxillofac Implants. 1995 May-Jun;10(3):303-11.

Reference Type BACKGROUND
PMID: 7615326 (View on PubMed)

Raghoebar GM, Batenburg RH, Timmenga NM, Vissink A, Reintsema H. Morbidity and complications of bone grafting of the floor of the maxillary sinus for the placement of endosseous implants. Mund Kiefer Gesichtschir. 1999 May;3 Suppl 1:S65-9. doi: 10.1007/PL00014520.

Reference Type BACKGROUND
PMID: 10414086 (View on PubMed)

Misch CE. Implant design considerations for the posterior regions of the mouth. Implant Dent. 1999;8(4):376-86. doi: 10.1097/00008505-199904000-00008.

Reference Type BACKGROUND
PMID: 10709483 (View on PubMed)

Lundgren S, Andersson S, Gualini F, Sennerby L. Bone reformation with sinus membrane elevation: a new surgical technique for maxillary sinus floor augmentation. Clin Implant Dent Relat Res. 2004;6(3):165-73.

Reference Type BACKGROUND
PMID: 15726851 (View on PubMed)

Sohn DS, Lee JS, Ahn MR, Shin HI. New bone formation in the maxillary sinus without bone grafts. Implant Dent. 2008 Sep;17(3):321-31. doi: 10.1097/ID.0b013e318182f01b.

Reference Type BACKGROUND
PMID: 18784532 (View on PubMed)

Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part III: leucocyte activation: a new feature for platelet concentrates? Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Mar;101(3):e51-5. doi: 10.1016/j.tripleo.2005.07.010.

Reference Type BACKGROUND
PMID: 16504851 (View on PubMed)

Sakka S, Coulthard P. Bone quality: a reality for the process of osseointegration. Implant Dent. 2009 Dec;18(6):480-5. doi: 10.1097/ID.0b013e3181bb840d.

Reference Type BACKGROUND
PMID: 20009601 (View on PubMed)

Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Mar;101(3):e37-44. doi: 10.1016/j.tripleo.2005.07.008. Epub 2006 Jan 19.

Reference Type BACKGROUND
PMID: 16504849 (View on PubMed)

Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Mar;101(3):e45-50. doi: 10.1016/j.tripleo.2005.07.009. Epub 2006 Jan 10.

Reference Type BACKGROUND
PMID: 16504850 (View on PubMed)

Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL, Dohan AJ, Mouhyi J, Dohan DM. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Mar;101(3):e56-60. doi: 10.1016/j.tripleo.2005.07.011.

Reference Type BACKGROUND
PMID: 16504852 (View on PubMed)

Cho JS, Ko YN, Koo HY, Kang YC. Synthesis of nano-sized biphasic calcium phosphate ceramics with spherical shape by flame spray pyrolysis. J Mater Sci Mater Med. 2010 Apr;21(4):1143-9. doi: 10.1007/s10856-009-3980-1. Epub 2010 Jan 6.

Reference Type BACKGROUND
PMID: 20052521 (View on PubMed)

Ferraz MP, Monteiro FJ, Manuel CM. Hydroxyapatite nanoparticles: A review of preparation methodologies. J Appl Biomater Biomech. 2004 May-Aug;2(2):74-80.

Reference Type BACKGROUND
PMID: 20803440 (View on PubMed)

20. Best SM, Porter AE, Thian ES, Huang J: Bioceramics: Past, present and for the future. J Eur Ceram Soc 28: 1319, 2008.

Reference Type BACKGROUND

Bohner M, Baumgart F. Theoretical model to determine the effects of geometrical factors on the resorption of calcium phosphate bone substitutes. Biomaterials. 2004 Aug;25(17):3569-82. doi: 10.1016/j.biomaterials.2003.10.032.

Reference Type BACKGROUND
PMID: 15020131 (View on PubMed)

von Doernberg MC, von Rechenberg B, Bohner M, Grunenfelder S, van Lenthe GH, Muller R, Gasser B, Mathys R, Baroud G, Auer J. In vivo behavior of calcium phosphate scaffolds with four different pore sizes. Biomaterials. 2006 Oct;27(30):5186-98. doi: 10.1016/j.biomaterials.2006.05.051. Epub 2006 Jun 21.

Reference Type BACKGROUND
PMID: 16790273 (View on PubMed)

23. Kalita SJ, Bhardwaj a, Bhatt H a: Nanocrystalline calcium phosphate ceramics in biomedical engineering. Mater Sci Eng CBiomimetic Supramol Sist 27: 441, 2007.

Reference Type BACKGROUND

Mazor Z, Mamidwar S. Effect of Nanocrystalline Calcium Sulfate Bone Graft in a Bilateral Sinus-Augmentation Procedure: A Case Report. Clin Adv Periodontics. 2015 Feb;5(1):76-81. doi: 10.1902/cap.2013.130022.

Reference Type BACKGROUND
PMID: 32689744 (View on PubMed)

Mazor Z, Horowitz RA, Del Corso M, Prasad HS, Rohrer MD, Dohan Ehrenfest DM. Sinus floor augmentation with simultaneous implant placement using Choukroun's platelet-rich fibrin as the sole grafting material: a radiologic and histologic study at 6 months. J Periodontol. 2009 Dec;80(12):2056-64. doi: 10.1902/jop.2009.090252.

Reference Type BACKGROUND
PMID: 19961389 (View on PubMed)

Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007 May;39(2):175-91. doi: 10.3758/bf03193146.

Reference Type BACKGROUND
PMID: 17695343 (View on PubMed)

Boyne PJ, James RA. Grafting of the maxillary sinus floor with autogenous marrow and bone. J Oral Surg. 1980 Aug;38(8):613-6. No abstract available.

Reference Type RESULT
PMID: 6993637 (View on PubMed)

Aghaloo TL, Moy PK. Which hard tissue augmentation techniques are the most successful in furnishing bony support for implant placement? Int J Oral Maxillofac Implants. 2007;22 Suppl:49-70.

Reference Type RESULT
PMID: 18437791 (View on PubMed)

Fugazzotto PA, Vlassis J. Long-term success of sinus augmentation using various surgical approaches and grafting materials. Int J Oral Maxillofac Implants. 1998 Jan-Feb;13(1):52-8.

Reference Type RESULT
PMID: 9509780 (View on PubMed)

Hurzeler MB, Kirsch A, Ackermann KL, Quinones CR. Reconstruction of the severely resorbed maxilla with dental implants in the augmented maxillary sinus: a 5-year clinical investigation. Int J Oral Maxillofac Implants. 1996 Jul-Aug;11(4):466-75.

Reference Type RESULT
PMID: 8803342 (View on PubMed)

Smiler DG, Johnson PW, Lozada JL, Misch C, Rosenlicht JL, Tatum OH Jr, Wagner JR. Sinus lift grafts and endosseous implants. Treatment of the atrophic posterior maxilla. Dent Clin North Am. 1992 Jan;36(1):151-86; discussion 187-8.

Reference Type RESULT
PMID: 1737600 (View on PubMed)

Chanavaz M. Maxillary sinus: anatomy, physiology, surgery, and bone grafting related to implantology--eleven years of surgical experience (1979-1990). J Oral Implantol. 1990;16(3):199-209.

Reference Type RESULT
PMID: 2098563 (View on PubMed)

Jaffin RA, Berman CL. The excessive loss of Branemark fixtures in type IV bone: a 5-year analysis. J Periodontol. 1991 Jan;62(1):2-4. doi: 10.1902/jop.1991.62.1.2.

Reference Type RESULT
PMID: 2002427 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

open_sinus_augmentation

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.